Umbilical cord-derived mesenchymal stem cell therapy (Central South University)

N/A

Report date: 2024/11/21 20:00:04

Base Information

Drug NameUmbilical cord-derived mesenchymal stem cell therapy (Central South University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsPsoriasisPneumonia, ViralPneumonia, Ventilator-Associated
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesCentral South UniversityTuohua Biological Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTuohua Biological Technology Co LtdCentral South University
Active IndicationsN/A
Inactive IndicationsPsoriasisPneumonia, ViralPneumonia, Ventilator-Associated

Other Information

ATC CodeN/A
Related LinksN/A